• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植后外周血中 HDV RNA 迅速早期下降,但肝内肝炎 delta 抗原持续存在。

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.

机构信息

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.

出版信息

J Hepatol. 2012 Jan;56(1):115-22. doi: 10.1016/j.jhep.2011.06.016. Epub 2011 Jul 14.

DOI:10.1016/j.jhep.2011.06.016
PMID:21762665
Abstract

BACKGROUND & AIMS: Chronic HDV infection is an inflammatory liver disease and liver transplantation (LTX) remains the only curative treatment option for most patients. The hepatitis D virus (HDV) uses HBsAg as its surface protein, however, it is controversial to what extend HDV may be detected independently of HBsAg in blood and liver after LTX. The aims of this study were to investigate kinetics of HDV RNA and HBsAg early after LTX, to apply the data to a mathematical model and to study long-term persistence of HDV after LTX.

METHODS

We retrospectively analyzed 26 patients with chronic hepatitis delta who underwent LTX between 1994 and 2009. Blood samples were obtained every 1-3 days during the first 14 days after LTX. Data were applied to a mathematical model to study viral kinetics. Available liver biopsy samples were stained for HBV and HDV viral antigens and tested for HBV DNA/cccDNA.

RESULTS

HBsAg and HDV RNA became negative after a median of 5 days (range 1-13) and 4 days (range 1-10), respectively. Early HDV RNA and HBsAg decline paralleled almost exactly in all patients; however the mathematical model showed a high variability of virion death. HDAg stained positive in transplanted livers in six patients in the absence of liver HBV DNA/cccDNA, serum-HBsAg, and HDV RNA for up to 19 months after LTX.

CONCLUSIONS

HDV RNA and HBsAg decline follow almost identical kinetic patterns within the first days after LTX. Nevertheless, intrahepatic latency of HDAg has to be considered when exploring novel concepts to withdraw HBIG.

摘要

背景与目的

慢性 HDV 感染是一种炎症性肝病,肝移植(LTX)仍然是大多数患者的唯一治愈治疗选择。乙型肝炎病毒(HBV)使用 HBsAg 作为其表面蛋白,然而,HBV 抗原在 LTX 后血液和肝脏中是否可以独立于 HBsAg 检测到,这存在争议。本研究的目的是研究 LTX 后早期 HDV RNA 和 HBsAg 的动力学,将数据应用于数学模型,并研究 LTX 后 HDV 的长期持续存在。

方法

我们回顾性分析了 1994 年至 2009 年间接受 LTX 的 26 例慢性乙型肝炎 delta 患者。LTX 后第 1 至 14 天,每 1-3 天采集一次血样。数据应用于数学模型研究病毒动力学。可获得的肝活检样本进行 HBV 和 HDV 病毒抗原染色,并检测 HBV DNA/cccDNA。

结果

HBsAg 和 HDV RNA 在中位数为 5 天(范围 1-13)和 4 天(范围 1-10)后分别变为阴性。所有患者的早期 HDV RNA 和 HBsAg 下降几乎完全平行;然而,数学模型显示病毒粒子死亡的变异性很高。在 LTX 后长达 19 个月,在没有肝 HBV DNA/cccDNA、血清 HBsAg 和 HDV RNA 的情况下,六名患者的移植肝中 HDAg 染色阳性。

结论

HBV 抗原在 LTX 后最初几天内,HBV RNA 和 HBsAg 的下降遵循几乎相同的动力学模式。然而,在探索停止 HBIG 的新方法时,必须考虑 HDAg 的肝内潜伏性。

相似文献

1
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.肝移植后外周血中 HDV RNA 迅速早期下降,但肝内肝炎 delta 抗原持续存在。
J Hepatol. 2012 Jan;56(1):115-22. doi: 10.1016/j.jhep.2011.06.016. Epub 2011 Jul 14.
2
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.慢性丁型肝炎所致肝硬化肝移植后的长期临床和病毒学转归
Hepatology. 1995 Feb;21(2):333-9.
3
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.HBeAg 阳性的乙型肝炎 delta 感染:病毒学模式和临床长期转归。
Liver Int. 2012 Oct;32(9):1415-25. doi: 10.1111/j.1478-3231.2012.02831.x. Epub 2012 Jun 20.
4
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.慢性丁型肝炎中 HBsAg 和 HDV-RNA 的定量水平。
Liver Int. 2010 Mar;30(3):430-7. doi: 10.1111/j.1478-3231.2009.02140.x. Epub 2009 Oct 16.
5
Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.慢性丁型肝炎中丁型肝炎病毒RNA和乙型肝炎表面抗原血清水平的定量分析可改善治疗监测。
Antivir Ther. 2007;12(3):381-8.
6
Hepatitis delta in HIV-infected individuals in Europe.在欧洲,感染 HIV 的个体中的 delta 肝炎。
AIDS. 2011 Oct 23;25(16):1987-92. doi: 10.1097/QAD.0b013e32834babb3.
7
Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.将乙型肝炎表面抗原阳性肝脏移植给乙型肝炎病毒阳性受者以及丁型肝炎病毒合并感染的作用。
Liver Transpl. 2005 Aug;11(8):922-8. doi: 10.1002/lt.20471.
8
High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.蒙古表面健康个体中通过酶免疫测定法可检测到的丁型肝炎病毒感染高流行率。
J Med Virol. 2005 Jul;76(3):333-40. doi: 10.1002/jmv.20363.
9
Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.通过敏感定量检测法测定的已确诊慢性丁型肝炎病毒感染患者血清中的乙型肝炎病毒浓度。
J Med Virol. 2001 Nov;65(3):478-84.
10
Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.韩国慢性乙型肝炎患者中丁型肝炎病毒合并感染的流行率和临床意义。
J Med Virol. 2011 Jul;83(7):1172-7. doi: 10.1002/jmv.22095. Epub 2011 May 3.

引用本文的文献

1
Chronic Hepatitis B in the Transplant Setting: A 30-Year Experience in a Single Tertiary Italian Center.移植环境中的慢性乙型肝炎:意大利一家三级中心的30年经验
Viruses. 2025 Mar 21;17(4):454. doi: 10.3390/v17040454.
2
Hepatitis Delta Virus and Hepatocellular Carcinoma.丁型肝炎病毒与肝细胞癌
Pathogens. 2024 Apr 27;13(5):362. doi: 10.3390/pathogens13050362.
3
Quantitative methods for optimizing patient outcomes in liver transplantation.肝移植中优化患者预后的定量方法。
Liver Transpl. 2024 Mar 1;30(3):311-320. doi: 10.1097/LVT.0000000000000325. Epub 2023 Dec 25.
4
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection.慢性丁型和乙型肝炎患者的循环 miRNA 谱具有可比性,但与 HBeAg 阴性 HBV 感染个体的 miRNA 谱不同。
Viruses. 2023 Nov 15;15(11):2257. doi: 10.3390/v15112257.
5
Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries.乙型肝炎和丁型肝炎的病毒诊断:我们所知与仍需了解的内容?特别关注低收入和中等收入国家
Microorganisms. 2022 Oct 22;10(11):2096. doi: 10.3390/microorganisms10112096.
6
KASL clinical practice guidelines for management of chronic hepatitis B.《慢性乙型肝炎管理的KASL临床实践指南》
Clin Mol Hepatol. 2022 Apr;28(2):276-331. doi: 10.3350/cmh.2022.0084. Epub 2022 Apr 1.
7
Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin.丁型肝炎病毒(HDV)和类丁型因子:对其起源的见解
Front Microbiol. 2021 Jun 21;12:652962. doi: 10.3389/fmicb.2021.652962. eCollection 2021.
8
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.2021 年的丁型肝炎病毒:病毒学、免疫学和针对难治性疾病的新治疗方法。
Gut. 2021 Sep;70(9):1782-1794. doi: 10.1136/gutjnl-2020-323888. Epub 2021 Jun 8.
9
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition.乙型和丁型肝炎病毒感染中的固有免疫:对病毒持续存在、炎症和 T 细胞识别的影响。
Semin Immunopathol. 2021 Aug;43(4):535-548. doi: 10.1007/s00281-021-00864-x. Epub 2021 May 21.
10
HDV Pathogenesis: Unravelling Ariadne's Thread.HDV 发病机制:揭开阿里阿德涅线团之谜。
Viruses. 2021 Apr 28;13(5):778. doi: 10.3390/v13050778.